Clinical Laserthermia Systems AB (publ)
CLS-B.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$56.55M
Close$
Share Statistics
| Market cap | $56.55 Million |
|---|---|
| Enterprise Value | $52.74 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.61 |
| Beta | -0.09 |
| Outstanding Shares | 31,166,594 |
Return
| Return on Equity | -82.56% |
|---|---|
| Return on Assets | -59.33% |
| Return on Invested Capital | -98.74% |
Valuation & Multiples
| P/E Ratio | -1.33 |
|---|---|
| PEG | -1.47 |
| Price to Sales | - |
| Price to Book Ratio | 1.77 |
| Enterprise Value to Revenue | 4.2 |
| Enterprise Value to EBIT | -1.3 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 17, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$6.60 M
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$8.60 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Clinical Laserthermia Systems AB (publ)
13 employees
CEO: Dan J. Mogren Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the targe...